Likes Subject
active and good volume, but down sundoctor 02/08/23 4:37 PM
This won't happen. The government is in bed trading.jeff 02/08/23 1:19 PM
There is one way to stop big pharma
Bullish
Bullish
gkare 02/08/23 1:13 PM
BP doesn't want things to work, whether from trading.jeff 02/08/23 11:41 AM
Sad that the process works so well on stocksmanjr 02/08/23 11:20 AM
OTC DISCLOSURE & NEWS SERVICE pistol2 02/08/23 9:46 AM
Pink current on otc JettaR 02/08/23 8:42 AM
CDC bacteria news out
Bullish
Bullish
sundoctor 02/08/23 8:10 AM
testing from MMs.
Bullish
Bullish
sundoctor 02/07/23 5:52 PM
I can feel it ready to run! :)
Bullish
Bullish
retired early 02/07/23 9:33 AM
form t: buy 1,500,000 at 0.010725
Bullish
Bullish
sundoctor 02/06/23 10:05 PM
Volume picking up! Hoping for PR soon regarding
Bullish
Bullish
bige777 02/06/23 6:57 PM
I'll take it
Bullish
Bullish
gkare 02/03/23 7:26 PM
Beautiful ending!! Have a good weekend everyone. Art85 02/03/23 4:02 PM
If you have watched football recently, you see retired early 02/02/23 3:57 PM
Small Ball Ask taps, with weak Bid Support. work-n-hard 02/02/23 9:56 AM
They need weekly PR's to get this moving. gkare 02/01/23 7:32 PM
Funding in place. Huge volume today! Blast off.
Bullish
Bullish
bige777 02/01/23 6:25 PM
may develop treatmental chips for some diseases or
Bullish
Bullish
sundoctor 01/31/23 7:22 PM
#BreakingNews $HALB Animal Tests at #MSU To Develop Singhania 01/31/23 11:18 AM
Halberd to Conduct Animal Tests of Nasal Spray pistol2 01/31/23 9:02 AM
news out sundoctor 01/31/23 8:09 AM
form t: 475367 sundoctor 01/30/23 6:57 PM
Looks like it is. :) retired early 01/30/23 9:49 AM
Good volume yesterday and today. Hope the snowball
Bullish
Bullish
bige777 01/27/23 7:26 PM
We're lucky enough to have loaded up while retired early 01/27/23 2:05 PM
Just ONE successful animal test result and this
Bullish
Bullish
gkare 01/25/23 8:07 PM
Way way up. And no one knows about it
Bullish
Bullish
gkare 01/25/23 8:02 PM
MSU's animal testing and CDC samples equals up,
Bullish
Bullish
bige777 01/25/23 3:32 PM
Yes, probably last year was casual discussions about gkare 01/24/23 12:13 PM
Just read the PR that you referred to. trading.jeff 01/24/23 11:49 AM
#BreakingNews Halberd $HALB Agrees to Animal Testing at Singhania 01/24/23 9:47 AM
See PR on June 8, 2022. Discussions started gkare 01/24/23 9:41 AM
Wasn't there an agreement to do this testing trading.jeff 01/24/23 9:29 AM
run sundoctor 01/24/23 8:54 AM
$HALB Halberd Agrees to Animal Testing at Mississippi
Bullish
Bullish
Louied91 01/24/23 8:36 AM
Ugly shit if you have a personal ethical standard.... XenaLives 01/20/23 4:09 PM
Once you get money like MMs, HALB becomes sundoctor 01/14/23 8:38 PM
Shell history is important: XenaLives 01/14/23 7:22 PM
HALB - Decades of lies.. XenaLives 01/14/23 6:23 PM
HALB is a shit shell with a shitty XenaLives 01/14/23 6:04 PM
Can’t argue that. If they actually pulled off work-n-hard 01/13/23 11:18 AM
You might be right but it's all a retired early 01/13/23 10:55 AM
Bled off a few more this afternoon. This work-n-hard 01/12/23 4:14 PM
Is it just me or does it seem gkare 01/11/23 8:34 PM
up step by step, but no volume?
Bullish
Bullish
sundoctor 01/09/23 6:58 PM
Need volume. work-n-hard 01/06/23 10:24 AM
$HALB terrific bounce back chart, from.005's earlier this
Bullish
Bullish
Screech691 01/06/23 7:55 AM
Was this a long term gap ,fill from stocksmanjr 01/05/23 4:58 PM
Volume comes in and money will be made. work-n-hard 01/05/23 10:33 AM
Likes Subject

sundoctor
02/08/23 4:37 PM
trading.jeff
02/08/23 1:19 PM
gkare
02/08/23 1:13 PM
trading.jeff
02/08/23 11:41 AM
stocksmanjr
02/08/23 11:20 AM
pistol2
02/08/23 9:46 AM
JettaR
02/08/23 8:42 AM
sundoctor
02/08/23 8:10 AM
sundoctor
02/07/23 5:52 PM
retired early
02/07/23 9:33 AM
sundoctor
02/06/23 10:05 PM
gkare
02/03/23 7:26 PM
retired early
02/02/23 3:57 PM
work-n-hard
02/02/23 9:56 AM
sundoctor
01/31/23 8:09 AM
sundoctor
01/30/23 6:57 PM
retired early
01/30/23 9:49 AM
retired early
01/27/23 2:05 PM
gkare
01/25/23 8:02 PM
trading.jeff
01/24/23 11:49 AM
trading.jeff
01/24/23 9:29 AM
sundoctor
01/24/23 8:54 AM
run
sundoctor
01/14/23 8:38 PM
XenaLives
01/14/23 7:22 PM
XenaLives
01/14/23 6:23 PM
XenaLives
01/14/23 6:04 PM
work-n-hard
01/13/23 11:18 AM
retired early
01/13/23 10:55 AM
work-n-hard
01/12/23 4:14 PM
gkare
01/11/23 8:34 PM
sundoctor
01/09/23 6:58 PM
work-n-hard
01/06/23 10:24 AM
stocksmanjr
01/05/23 4:58 PM
work-n-hard
01/05/23 10:33 AM

Halberd Corp. (HALB)

Followers
288
Posters
Posts (Today)
8
Posts (Total)
25482
Created
02/15/11
Type
Free
Moderators

 

 

HALBERD CORPORATION 


                                                                                   




https://halberdcorporation.com/

                
Email: support@halberdcorporation.com

HALB Security Details - https://www.otcmarkets.com/stock/HALB/security


Share Structure

Authorized Shares -    800,000,000 - a/o 11/03/2022

Shares Outstanding -  515,874,842 - a/o 11/03/2022

Float-  322,571,082 - a/o 04/30/2022


 

 Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.            

                                                                              
                                                                                      
HALB holds the exclusive rights to 3 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629



See YouTube video, https://youtu.be/BGdZqHH6oew, concerning Dr. Felder’s discussion of the scientific basis underlying Premier’s extracorporeal treatment process for fighting cancer and other diseases.
 

 

                                                                                                                                                                                                                                                         Halberd Corporation Pursues Extracorporeal Radio Frequency Treatment  Against Covid-19 | BioSpace
 

In plain English: Halberd Corporation is a biotechnology company and with its partners (Dr. Qiang Shawn Chen and his team at Arizona State University; Dr. William Sturrus and his team at Youngstown State University) is developing an extra-corporeal (out of the body) treatment against PTSD, CTE, Alzheimer's Disease and other virusses and diseases. With the use of antibodies the disease antigens is targeted. Using radiofrequency / laser technology the "antibody-metallic moiety-antigens complex" is destroyed/eradicated. All based on 3 granted patents and 20 provisional (some PCT) patent applications.
                                                                                                                                                                                                               

                                                                                                                                                                                                            

Halberd Corporation's Proprietary Technology for Alzheimer's Disease Enters Stage 4 of 7 Stage Process

Jackson Center, Pennsylvania--(Newsfile Corp. - June 21, 2021) - Halberd Corporation's (OTC Pink: HALB) proprietary technology enters stage 4 to address Alzheimer's Disease (and other potential diseases), eradicating the antibody-disease combination through radiofrequency waves or laser or other means. Currently, there is no known effective treatment for Alzheimer's Disease which afflicts over 40 million people worldwide, equivalent to the combined population of the states of Florida and New York.

                                                                                            The seven (7) stages in Halberd's program are as follows:

  1.                                                                                                                                                                              1. Identifying target disease(s); (Done yes)
                                                                                                                                                                                 2. Creating patentable antibodies vs target disease(s); (Done yes)
                                                                                                                                                                                 3. Combining antibodies with metallic particles; (Done yes)
                                                                                                                                                                                 4. Eradicating the antibody-disease combination through radiofrequency waves, laser or other proprietary means; (Done yes)
                                                                                                                                                                                 5. Conducting animal tests to establish the safety and efficacy; (Planning phase with MSU, contract with mci Consultants Inc for FDA regulations/process yes)
                                                                                                                                                                                 6.Conducting human testing
                                                                                                                                                                                 7. Obtaining FDA Certification


     

Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished"


https://www.accesswire.com/652434/Halberd-Corporations-Proprietary-Technology-for-Alzheimers-Disease-Enters-Stage-4-of-7-Stage-Process
 

CEO William Hartman: "The principal competitive Alzheimer's drug treatment available today eliminates 5-15% of Beta Amyloid after one month of treatment costing over $50,000 per year. Halberd's extracorporeal process eradicates 100% within just 10 minutes."





                                                                                                                                                                                    



HALBERD'S 2022 GOALS:

* Halberd's on-going independent audit is anticipated to be completed within Q1 2022 yes

* Efforts are underway on filing Halberd's FORM-10 contingent on the completion of its independent audit leading to OTCQX exchange up-list by or within Q2 2022 yes

* Completion of the Top Ten Target Antigen elimination from CSF is expected to be completed within Q1 2022 yes

* Establish and execute meetings with the NFL and possibly the NCAA to seek endorsement for Halberd's PTSD/CTE research yes

* Discussions have commenced and are in progress with a large medical university to develop potential cures for several neurodegenerative diseases with potential independent validation within the year 2022. We plan on sharing the name of this university once an agreement is established (MSU and/or YSU, agreement not yet executed) yes

* We are looking into conducting initial discussions with an identified pharmaceutical company for potential partnering arrangements (ongoing)

* The next steps in Halberd's R&D program include eradication of the "Top Ten Target Antigens" from blood elements (serum and plasma), started in Q3 2022

* Plans are underway for generating scientific articles for publication within Q1 2022. The material will be carefully screened for patentable content prior to publication to protect our intellectual property and achievements

* Halberd is currently searching for an infectious disease specialist to be added to its company staff within Q1 2022 to assist in developing and testing cures for infectious diseases which have the potential of being treated with Halberd's proprietary technology yes

* Conclude current ongoing talks with a major university to acquire related abandoned intellectual property that could expand Halberd's value significantly

* Continue to protect Halberd's intellectual property by timely filing of patent applications

                      

     

 

_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

 




 

 

 
 

 

 
 

 

 

Most Liked Posts
(Last 30 Days)
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Most Liked Posts
(Last 30 Days)
New Post